IMGN Financial Facts

Net loss: -22.28M
Loss from operations: -21.91M
See Full Income Statement

Unbilled revenue: 784K
Other assets: 108K
See Full Balance Sheet

Immunogen Inc. (IMGN) Earnings

  |   Expand Research on IMGN
Next EPS Date 1/30/15 EPS Growth Rate -200.0%
Average EPS % Beat Rate -43.4% Revenue Growth Rate +23.9%
Average % Move 1-Wk after EPS -1.8% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
1/30/15 Q215 N/A-$0.04 N/A N/A$37.3M N/A N/A N/A
10/24/14 Q115 -$0.26-$0.15 -$0.11$13.2M$21.8M N/A Details
8/1/14 Q414 -$0.83-$0.32 -$0.51$5.74M$9.72M N/A Details
4/25/14 Q314 -$0.44-$0.27 -$0.17$6.9M$13.28M = Details
1/31/14 Q214 $0.04-$0.18 +$0.22$30.1M$18.16M = Details
10/25/13 Q114 -$0.13-$0.23 +$0.10$17.2M$12.1M = Details
8/2/13 Q413 -$0.26-$0.30 +$0.04$3.83M$3.44M = Details
4/26/13 Q313 -$0.02-$0.15 +$0.13$25M$11.94M N/A Details